CalciMedica (CALC) Other financing activities (2019 - 2025)
CalciMedica's (CALC) quarterly Other financing activities came in at $25000.0 in Q3 2025, up 56.25% YoY from $16000.0 in Q3 2024, and up 56.25% on a QoQ basis from $16000.0 in Q3 2024.
CalciMedica (CALC) Other financing activities (2019 - 2025) Analysis & Trends
CalciMedica (CALC) has 6 years of Other financing activities data on file, last reported at $25000.0 in Q3 2025.
- Quarterly Other financing activities rose 56.25% year-over-year to $25000.0 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $41000.0 (up 156.25% YoY) and the FY2025 annual result came in at $25000.0, up 25.0% from the prior year.
- Other financing activities improved to $25000.0 in Q3 2025, from $16000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $495000.0 in Q2 2021 to a low of $1000.0 in Q1 2022.
- A 4-year average of $94125.0 and a median of $26000.0 in 2021 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2021 — Other financing activities soared 4025.0% — and 2022, when it plunged 98.91%.
- Tracing CALC's Other financing activities over 4 years: stood at $81000.0 in 2021, then sank by 80.25% to $16000.0 in 2022, then changed by 0.0% to $16000.0 in 2024, then jumped by 56.25% to $25000.0 in 2025.
- The last three Other financing activities figures came in at $25000.0 (Q3 2025), $16000.0 (Q3 2024), and $16000.0 (Q2 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.52 Bn | 132.67 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.55 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.31 Bn | 60.13 Bn | 1.37 Bn |
| 4 | Moderna | 61.77 Bn | 56.64 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.26 Bn | 37.16 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.19 Bn | 27.88 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.71 Bn | 10.31 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.52 Bn | - |
| 10 | CalciMedica | 10.06 Mn | -8.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 25,000.00 |
| Sep 30, 2025 | 25,000.00 |
| Sep 30, 2024 | 16,000.00 |
| Sep 30, 2024 | 16,000.00 |
| Jun 30, 2022 | 16,000.00 |
| Jun 30, 2022 | 16,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Dec 31, 2021 | 81,000.00 |
| Dec 31, 2021 | 81,000.00 |
| Sep 30, 2021 | 27,000.00 |
| Sep 30, 2021 | 27,000.00 |
| Jun 30, 2021 | 495,000.00 |
| Jun 30, 2021 | 495,000.00 |
| Mar 31, 2021 | 92,000.00 |
| Mar 31, 2021 | 92,000.00 |
| Sep 30, 2020 | 54,000.00 |
| Sep 30, 2020 | 54,000.00 |
| Jun 30, 2020 | 12,000.00 |
| Jun 30, 2020 | 12,000.00 |